Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Early Feasibility Study to Assess Safety and Device Performance of AcoustiCare™

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03751904
Recruitment Status : Withdrawn (Sponsor is no longer pursuing the study.)
First Posted : November 23, 2018
Last Update Posted : January 29, 2019
Sponsor:
Information provided by (Responsible Party):
Signature Medical, Inc.

Brief Summary:
AcoustiCareTM is a non-invasive clinical tool used for the detection of intracardiac pressures using heart sounds in patients with heart failure.

Condition or disease Intervention/treatment Phase
Heart Failure,Congestive Device: AcoustiCare Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 0 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Early Feasibility Study to Assess Safety and Device Performance of AcoustiCare™
Actual Study Start Date : January 25, 2019
Estimated Primary Completion Date : February 28, 2019
Estimated Study Completion Date : March 30, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Failure

Arm Intervention/treatment
AcoustiCare
Single Arm
Device: AcoustiCare
Electronic stethoscope




Primary Outcome Measures :
  1. Incidence of Adverse Events [ Time Frame: Subjects will be assessed for adverse events through study completion, an average of 1 day ]
    The safety of the Acousticare device will be assessed by reviewing adverse events in all patients enrolled in the study



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Male or female subjects between the ages of 18 - 80 years
  2. Willing and able to sign informed consent form
  3. Normal subjects without a history of heart disease who are recruited from the surrounding community
  4. Subjects with heart failure undergoing treatment in a hospital setting

Exclusion Criteria:

  1. Hemodynamic instability (Systolic BP>180 or <90 and Diastolic BP>90 and <60)
  2. Acute coronary syndrome
  3. Prior heart transplant recipients
  4. Subjects who are pacemaker dependent
  5. Severe obesity (body mass index > 40 kg/m2)
  6. Subjects who are pregnant
Layout table for additonal information
Responsible Party: Signature Medical, Inc.
ClinicalTrials.gov Identifier: NCT03751904    
Other Study ID Numbers: SIG-0001
First Posted: November 23, 2018    Key Record Dates
Last Update Posted: January 29, 2019
Last Verified: January 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Heart Failure
Heart Diseases
Cardiovascular Diseases